Turning innovation into better care
Everything youneed to know —built for your practice.
The latest drugs, devices, diagnostics and evidence — translated into clear, practical insights for physicians.
Latest Updates
- FDA approval
First selective D1/D5 dopamine agonist approved for Parkinson's disease.
Juvmo (tavapadon) · AbbVie
- FDA De Novo
First wearable sensor that tracks ketones and glucose together.
Libre Duo · Abbott
- FDA approval
A second blood-based colorectal cancer screening test reaches the US market.
SimpleScreen CRC · Freenome
- FDA De Novo
The first soft-tissue surgical robot with its arms built into the operating table.
OTTAVA Robotic Surgical System · Johnson & Johnson
- FDA clearance
AI flags hidden structural heart disease from a routine 12-lead ECG.
EchoNext · Pathway Labs
- FDA approval (companion diagnostic)
A ctDNA test now selects bladder cancer patients for adjuvant immunotherapy.
Signatera CDx · Natera
- FDA De Novo
Machine-learning MRI aid helps tell MSA-P and PSP apart from Parkinson's.
neuropacs · Neuropacs
- FDA premarket approval
The first transcatheter valve with a dedicated aortic regurgitation indication.
Trilogy Transcatheter Heart Valve · JenaValve Technology
- FDA approval
The first oral peptide that blocks the IL-23 receptor, approved for plaque psoriasis.
Icotyde (icotrokinra) · Johnson & Johnson
- FDA premarket approval
An extended-depth-of-focus IOL with contrast comparable to a monofocal.
TECNIS PureSee IOL · Johnson & Johnson
- FDA approval (expanded indication)
rhBMP-2 bone graft is now approved for one- and two-level TLIF.
Infuse Bone Graft for TLIF · Medtronic
- FDA premarket approval
A wearable Tumor Treating Fields device for locally advanced pancreatic cancer.
Optune Pax · Novocure
Regulatory Timeline
View allFeatured Tools
View all- A1C CalculatorEstimate A1C reduction across treatmentsSoon
- Risk CalculatorCardiovascular, renal and moreSoon
- Treatment ComparatorSide-by-side innovations, from the primary source
- Guideline NavigatorFind key recommendations by conditionSoon
- Reimbursement CheckCoverage, PA and coding informationSoon
- Clinical TrialsFind ongoing trials for your patientsSoon
Trending Topics
Ranked by updates in the feed
Global Regulatory Watch
View all
- FDAU.S.12 updates
- EMAEuropeSoon
- PMDAJapanSoon
- NMPAChinaSoon
- TGAAustraliaSoon
Clinician Insights
Now we have a novel therapy that selectively targets D1/D5 receptors, which addresses a longstanding need for innovation and provides health care providers with greater flexibility to tailor treatment to individual patient needs.”